Millipore reports profit fall in third quarter
Massachusetts-based Millipore has reported a fall in net profit in its third quarter results, mainly due to increased costs and recent acquisition charges.
Archives for November 2, 2006
Covalent Group bags $8.2m worth of contracts
Covalent Group has managed to bag itself $8.2m (€6.5m) worth of clinical trial contracts with one pharma giant.
Acting FDA commissioner gives microdosing approval
The acting US FDA commissioner has given his endorsement to human microdosing studies for drug development in a show of backing that indicates the Agency is open to receive Exploratory IND applications to accelerate drug development.
Scientists improve cancer drug synthesis
Researchers have developed a more efficient and cost-saving method to make cladribine, a drug used for the treatment of certain types of leukaemia and potentially efficient against multiple sclerosis (MS).
Bionomics selects SAFC to manufacture 'new generation' cancer drug
Australian pharma company Bionomics has signed a deal with contract manufacturer SAFC Pharma for the scale-up of its flagship cancer drug.
Galapagos announces first natural compound collaboration
Genomics-based drug discovery company Galapagos, has struck a deal with LEO Pharma in an agreement that will see the firm use its natural compound collection for high throughput screening, hit verification, and profiling of selected compounds for LEO...